Literature DB >> 26275829

Overview of digital breast tomosynthesis: Clinical cases, benefits and disadvantages.

T Nguyen1, G Levy2, E Poncelet2, T Le Thanh2, J F Prolongeau3, J Phalippou3, F Massoni3, N Laurent2.   

Abstract

In France, the national breast cancer-screening program is based on mammography combined with clinical breast examination, and sometimes breast ultrasound for patients with high breast density. Digital breast tomosynthesis is a currently assessed 3D imaging technique in which angular projections of the stationary compressed breast are acquired automatically. When combined with mammography, clinicians can review both conventional (2D) as well as three-dimensional (3D) data. The purpose of this article is to review recent reports on this new breast imaging technique and complements this information with our personal experience. The main advantages of tomosynthesis are that it facilitates the detection and characterization of breast lesions, as well as the diagnosis of occult lesions in dense breasts. However, to do this, patients are exposed to higher levels of radiation than with 2D mammography. In France, the indications for tomosynthesis and its use in breast cancer-screening (individual and organized) are yet to be defined, as is its role in the diagnosis and staging of breast cancer (multiple lesions). Further studies assessing in particular the combined reconstruction of the 2D view using 3D tomosynthesis data acquired during a single breast compression event, and therefore reducing patient exposure to radiation, are expected to provide valuable insight.
Copyright © 2015 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Breast cancer; Mammography; Mastology; Tomosynthesis

Mesh:

Year:  2015        PMID: 26275829     DOI: 10.1016/j.diii.2015.03.003

Source DB:  PubMed          Journal:  Diagn Interv Imaging        ISSN: 2211-5684            Impact factor:   4.026


  2 in total

1.  Whole-genome circulating tumor DNA methylation landscape reveals sensitive biomarkers of breast cancer.

Authors:  Luo Hai; Lingyu Li; Zongzhi Liu; Zhongsheng Tong; Yingli Sun
Journal:  MedComm (2020)       Date:  2022-06-17

2.  Whole-genome bisulfite sequencing analysis of circulating tumour DNA for the detection and molecular classification of cancer.

Authors:  Yibo Gao; Hengqiang Zhao; Ke An; Zongzhi Liu; Luo Hai; Renda Li; Yang Zhou; Weipeng Zhao; Yongsheng Jia; Nan Wu; Lingyu Li; Jianming Ying; Jie Wang; Binghe Xu; Zhihong Wu; Zhongsheng Tong; Jie He; Yingli Sun
Journal:  Clin Transl Med       Date:  2022-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.